Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
East Carolina University, Brody School of Medicine, Greenville, North Carolina, USA.
Presenters Ornella
PO
Potter
Nadyah
N
John
Discussant Barbara J
DB
Coffey
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D001249:Asthma / Q000150:complications; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002637:Chest Pain; D002648:Child; D004409:Dyskinesia, Drug-Induced / Q000523:psychology*; D005190:Family; D005260:Female; D016316:Guanfacine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D018021:Lithium Chloride / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D019964:Mood Disorders / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D009483:Neuropsychological Tests; D009765:Obesity / Q000150:complications; D017374:Paroxetine / Q000009:adverse effects; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D019338:Polypharmacy; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011595:Psychomotor Agitation / Q000188:drug therapy; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D012907:Smoking / Q000009:adverse effects; D012931:Social Environment
D000316:Adrenergic alpha-Agonists; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D000068180:Aripiprazole; D016316:Guanfacine; D018021:Lithium Chloride; D017374:Paroxetine; D010879:Piperazines; D015363:Quinolones; D017367:Selective Serotonin Reuptake Inhibitors